BACKGROUND: Accumulating data indicate that human epidermal growth factor receptor-2 (HER2)-positive breast cancer is a heterogeneous disease. We undertook a study to correlate lipid profiles with heterogeneous clinicopathological features of HER2-positive breast cancer. MATERIALS AND METHODS: Histology-directed matrix-assisted laser desorption/ionization (MALDI)-mass spectrometry (MS) analyses were performed on 22 retrospective frozen tissue samples collected from patients with HER2-positive metastatic breast cancer, in order to correlate lipid profiles with clinicopathological characteristics. Additionally, a pair of tumor and adjacent normal tissue was profiled to identify cancer-associated changes in lipid profiles. RESULTS: Sphingomyelin 34:1, phosphatidylcholine (PC) 32:0, and PC 34:1, and PC 36:2 were overexpressed in HER2-positive breast cancer compared to adjacent normal tissue (HER2 signature). Lipid MALDI-MS profiles were different between Ki-67-high and Ki-67-low tumors. The proliferation signature (Ki-67-high vs. Ki-67-low) and the HER2 signature (cancer vs. normal) did not significantly overlap with each other. CONCLUSION: For the first time to our knowledge, this study describes lipid profiles correlated with various clinicopathological characteristics of HER2-positive breast cancer. Lipid profiling might be helpful for the molecular characterization of this disease.
BACKGROUND: Accumulating data indicate that human epidermal growth factor receptor-2 (HER2)-positive breast cancer is a heterogeneous disease. We undertook a study to correlate lipid profiles with heterogeneous clinicopathological features of HER2-positive breast cancer. MATERIALS AND METHODS: Histology-directed matrix-assisted laser desorption/ionization (MALDI)-mass spectrometry (MS) analyses were performed on 22 retrospective frozen tissue samples collected from patients with HER2-positive metastatic breast cancer, in order to correlate lipid profiles with clinicopathological characteristics. Additionally, a pair of tumor and adjacent normal tissue was profiled to identify cancer-associated changes in lipid profiles. RESULTS:Sphingomyelin 34:1, phosphatidylcholine (PC) 32:0, and PC 34:1, and PC 36:2 were overexpressed in HER2-positive breast cancer compared to adjacent normal tissue (HER2 signature). Lipid MALDI-MS profiles were different between Ki-67-high and Ki-67-low tumors. The proliferation signature (Ki-67-high vs. Ki-67-low) and the HER2 signature (cancer vs. normal) did not significantly overlap with each other. CONCLUSION: For the first time to our knowledge, this study describes lipid profiles correlated with various clinicopathological characteristics of HER2-positive breast cancer. Lipid profiling might be helpful for the molecular characterization of this disease.
Entities:
Keywords:
HER2; MALDI; breast cancer; lipid; profiles
Authors: Jae Hun Jung; Min Young Lee; Do-Young Choi; Jae Won Lee; Sungyong You; Kye Young Lee; Jayoung Kim; Kwang Pyo Kim Journal: Proteomics Date: 2015-01-16 Impact factor: 3.984
Authors: Lauren M Petrick; Courtney Schiffman; William M B Edmands; Yukiko Yano; Kelsi Perttula; Todd Whitehead; Catherine Metayer; Craig E Wheelock; Manish Arora; Hasmik Grigoryan; Henrik Carlsson; Sandrine Dudoit; Stephen M Rappaport Journal: Cancer Lett Date: 2019-03-20 Impact factor: 8.679
Authors: Natalia L Starodubtseva; Vitaliy V Chagovets; Maria E Nekrasova; Niso M Nazarova; Alisa O Tokareva; Olga V Bourmenskaya; Djamilja I Attoeva; Eugenii N Kukaev; Dmitriy Y Trofimov; Vladimir E Frankevich; Gennady T Sukhikh Journal: Metabolites Date: 2022-05-31
Authors: Michelle M Mielke; Veera Venkata Ratnam Bandaru; Dingfen Han; Yang An; Susan M Resnick; Luigi Ferrucci; Norman J Haughey Journal: Aging Cell Date: 2014-10-24 Impact factor: 9.304
Authors: Narine M Tonoyan; Vitaliy V Chagovets; Natalia L Starodubtseva; Alisa O Tokareva; Konstantin Chingin; Irena F Kozachenko; Leyla V Adamyan; Vladimir E Frankevich Journal: Sci Rep Date: 2021-06-01 Impact factor: 4.379
Authors: E Ellen Jones; Shaalee Dworski; Daniel Canals; Josefina Casas; Gemma Fabrias; Drew Schoenling; Thierry Levade; Chadrick Denlinger; Yusuf A Hannun; Jeffrey A Medin; Richard R Drake Journal: Anal Chem Date: 2014-08-08 Impact factor: 6.986